SYGNIS Launches SunScript™ One Step Reverse Transcriptase-PCR Kit
Complete the form below to unlock access to ALL audio articles.
SYGNIS AG has announced the global launch of SunScript™ One Step Reverse Transcriptase (RT)-PCR Kit, the second product of its SunScript™ product line for parallel transcription and amplification of genomic information for a multitude of applications in molecular biology and diagnostics research.
SunScript™ One Step RT-PCR Kit is an easy and reliable system designed for fast, specific and sensitive end point RT-PCR reactions. The kit contains all the components needed to perform both reverse transcription and PCR amplification in the same single tube by using gene specific primers, in a “one step” reaction. This minimizes contaminations and constitutes a convenient system to process multiple samples.
The novel high-temperature One Step RT-PCR kit is based on the combination of SunScript™ Reverse Transcriptase RNaseH- and high-quality Taq Polymerase for the reverse transcription and PCR amplification of specific RNA fragments in one convenient single step.
SunScript™ enzymes provide an improved thermal stability for the RT step, allowing temperatures of up to 85˚C resolving even the most complicated RNA structures to obtain a faithful picture of the original genetic information accompanied by high yields of DNA in the amplification step.
Additional advantages consist in the exquisite sensitivity, the high reproducibility of reactions, the ability to amplify difficult RNAs with complex secondary structures and an easy single step handling.
RTs are commonly used in molecular biology to convert genetic information from RNA molecules back to DNA, enabling a number of downstream analyses of RNA molecules using DNA analysis methods such as next generation sequencing or polymerase chain reaction (PCR) in gene expression profiling and molecular diagnostics.
“We are very proud and excited about the launch of SunScript™ One Step RT-PCR Kit, our second product of the SunScript™ product line. This product allows us to address the PCR reagent kit market, a market that is estimated by market experts of WhaTech Channel to reach a value of US$4.3 billion by 2019 with a CAGR of 14.2%,” Pilar de la Huerta, CEO and CFO of SYGNIS commented. “Since the launch of the first product beginning this year we built a strong portfolio of products with superior features. With this portfolio we position the Company as a leading provider of innovative and superior tools for processing genetic information for a multitude of applications in fast growing markets such as human genetics, oncology, molecular diagnostics and personalized medicine.”
The SunScript™ One Step RT-PCR Kits are in stock and will be globally commercialized mainly through the Company’s global network of distribution partners as well as the SYGNIS online shop under www.sygnis.com/shop.
SYGNIS has started an extensive promotional mailing campaign to all potential users in the molecular biology field. The Company plans a wide range of additional marketing events around the product launch including presentations at key international scientific meetings and conferences including the Single-Cell Genomics Meeting in the Netherlands, the ASHG (American Society Human Genetics) Annual Meeting 2015 in the US and the Single Cell Analysis & NGS Congress in the UK.
